July 2023–June 2024
THE COLLEGE
THE ROYAL AUSTRALIAN AND NEW ZEALAND COLLEGE OF RADIOLOGISTS (RANZCR)
OUR PURPOSE
To advance excellence in diagnostic, interventional, and cancer care medicine, to optimise health outcomes for our patients and society.
We deliver against our purpose through:
Members We meet (or exceed) member expectations, supporting them into, through, and beyond their career journey.
Our people We employ, develop, and encourage our people to align with our “member-centric” culture, to deliver outstanding solutions for our members.
Education We set the standard for world-class trainee and member training, education, and lifelong development, to drive clinical excellence.
Policy and advocacy We are the leading voice of our sector and through research and standards, shape the policy agenda with government, regulators, members and external stakeholders.
Organisational responsibility Under a strong governance structure, we operate within legal and regulator frameworks, in a socially responsible and financially sustainable manner.
BOARD OF DIRECTORS
OUR VALUES
RESPECT
We treat each other, our members, and our stakeholders with the same dignity and respect that we would expect for ourselves. We hold each other to this standard.
ACCOUNTABILITY
We take ownership and responsibility for our actions, behaviour, performance, and commitments.
INNOVATION
We encourage our people to imagine ‘what could be’; to be curious and brave. We recognise and celebrate new initiatives and advances in how we deliver our purpose.
INCLUSIVITY
We foster an inclusive and safe workplace where our diverse people and members are all welcome.
INTEGRITY
We maintain the confidence and trust of our stakeholders through our honesty, transparency, and authenticity.
Dr Peter O’ Brien Elected Fellow
Prof John Slavotinek President
Dr Kate O’Connor Elected Fellow
Dr Rajiv Rattan Dean, Faculty of Clinical Radiology
Dr Christian Wriedt Elected Fellow
Dr Gerry Adams Dean, Faculty of Radiation Oncology
Ms Yvonne Warner Non-Fellow
Prof Catherine Jones Elected Fellow
PRESIDENT’S MESSAGE
Prof John Slavotinek
An evolving environment and the need for adaptation have ever been faced by both living creatures and organisations such as RANZCR.
In recent years, the College has undergone rapid change under difficult conditions, largely those posed by COVID-19. More recent challenges reflect a politically driven desire to radically alter the healthcare landscape and constrain the role of medical colleges.
Since I took up the role of President just over six months ago, we have seen unusually numerous government ‘consultations’, parliamentary inquiries, requirements for extensive information with little notice, and at times conflicting requests from regulators. Meeting these challenges is not easy but as an incoming President, I have been privileged to inherit a well-run College with strong Councils in radiation oncology and clinical radiology, as well as an accomplished and balanced Board.
Of course, the continued support and dedication of our member volunteers and hard-working College staff have also been
instrumental in our success, and there are a number of initiatives and achievements that we can be particularly proud of.
Advocacy successes include implementation of the new MBS funding schedule for radiation therapy, effective from July 2024, which is a result of RANZCR’s decades-long advocacy. This marks a significant milestone in advancing equitable access to essential healthcare services. Long-term advocacy also led to the government decision to remove the need for MRI licenses by July 2027, giving patients full access to Medicare-funded MRI services.
Late last year we celebrated a significant accreditation achievement, with the AMC granting accreditation to RANZCR’s specialist medical training until 2026, with the opportunity to extend until 2029. This is the maximum permissible period, well beyond the result many other Colleges see, and an outstanding reflection on the quality of our training programs.
Our ASMs have been outstanding successes with record attendances at the Brisbane 2023 event and the recent New Zealand ASM.
The past year has also seen the continued roll-out of our Regional and Rural Training Pathway (RRTP) Pilot Program, which aims to address the unequal distribution of clinical radiologists and radiation oncologists across Australia. In New Zealand, successes include significant increases in the number of training positions in both specialties. We have also increased private sector training positions (on rotation) in New Zealand, for both clinical radiology (e.g. Taranaki and Invercargill) and
radiation oncology (Tauranga).
As past Chair of the AI Committee, I’m pleased to report that this year has seen RANZCR continuing our role as national and international leaders in this evolving landscape. Earlier this year a multisociety paper was published in leading radiology journals providing guidance about development, purchase, implementation and monitoring of AI tools. This initiative, proposed by RANZCR, resulted in collaboration between ACR, CAR, ESR, RANZCR and RSNA.
This serves as a model for further multi-society initiatives such as the collaborative effort dedicated to environmental issues that has just begun under ESR leadership.
AI Committee momentum continues with the development and release for consultation of position papers about autonomous AI as well as generative AI and large language models.
During the course of the last year, the CEO and College Board have embarked upon development of a new strategic plan. For the first time, this plan contemplates not just the next three years but also considers the more distant future.
As before, the plan outlines the short term in definitive terms but also addresses potential directions and activities that may be appropriate as the future unfolds.
In the coming year, our priorities will include education and professional development; advocacy for our professions; and supporting members to navigate increasingly rapid changes in technology. I look forward to another productive and collaborative 12 months and convey my thanks to all College members and staff for their contributions.
TREASURER’S REPORT
The Financial Statements for the year ending 30 June 2024, along with the Auditor’s Report, are presented in this document. A detailed version of the Financial Statements will be available on the College website www.ranzcr.com
Financial Year 2024 (FY24) marked another successful period, further solidifying the College’s financial position. The College generated an operating surplus of $6.5 million, exceeding budgetary expectations and an increase on FY23. This strong surplus position was driven by increased revenue across key areas—the benefit of a favourable macroeconomic climate on interest incomes—and effective expense management resulting in cost savings.
Operational revenues totaled $27.3 million, an increase on FY23 revenues of $23.2 million. Membership subscription revenues are the primary revenue source, contributing $13.2 million (48% of total revenue). This revenue also grew in FY24 by $1.4 million. Other key revenues include fees from International Medical Graduates, which grew by $0.5 million in FY24, to $1.5 million. Revenues from external interest and investment amounted to $2.3 million, growing by $0.6 million comparative to FY23.
Total expenses were $23.1 million, an increase on FY23 expenses of $21 million. Expenses were below budget across most operating areas.
The College maintains a robust
balance sheet position. Total assets currently stand at $62.5 million, offset by total liabilities of $25.6 million. This results in a strong asset-to-liability ratio of 2.4 times. Cash and external investments collectively total $45 million.
In alignment with the 20252040 Strategic Plan, the College is developing a comprehensive framework to prioritise investment allocation for the medium to long term.
RANZCR initiatives supporting College performance through FY24 are highlighted below.
Standards
In FY24, the College achieved significant milestones, including new CT Coronary Angiography (CTCA) training requirements that shift re-accreditation from logbooks to Continuing Professional Development (CPD). DOHAC funding facilitated webinars and a workshop for stillbirth investigation services and supported training development for Occupational Dust Lung Disease and Silicosis. The CPD Home was launched, attracting new Associate members. Additionally, funding was received for the National Lung Cancer Screening Program and radiologist training, with IR and INR post-fellowship programs set to launch in 2026.
Program Funding
The Regional and Rural Training Program (RRTP) pilot was launched in 2024 with several funded positions across the states. In 2025, the Federal Government
Dr Christian Wriedt
President’s Message
aims to fund additional positions specifically for Aboriginal and Torres Strait Islander trainees. The College also successfully filled all 52 STP (Specialty Training Program) and 6 IRTP (Integrated Rural Training Pathway) positions. The College will continue to advocate for ongoing funding and expansion of the RRTP beyond 2025.
Indigenous Trainee Support
The College successfully obtained a grant under the Flexible Approach to Training in Expanded Settings (FATES) initiative to fund an Indigenous Medical Educationalist (IME) and an Indigenous Trainee Liaison Officer (ITLO). Both the IME and the ITLO commenced in June 2024 and will work with Aboriginal and Torres Strait Islander trainees to support culturally safe training.
Accreditation
The Clinical Radiology and Radiation Oncology Training Accreditation Standards were recently approved and will be progressively implemented over the next year, with ample transition time provided to the sites.
Selection into Training
In 2024, the College introduced a new Selection-into-Training process. For the first time, applicants to both the CR and RO training programs will apply directly to the College to determine their eligibility to train. Applicants were required to obtain a College Registration Verification Number (CRVN) before applying
for a training position within a hospital. Further enhancements to the selection process will be introduced in the next two years to ensure that the College meets AMC / MCNZ requirements.
Memberships and Events
The American College of Radiology (ACR) training and education sessions were hosted in August. This was followed by the Brisbane ASM in October which had a record-breaking number of attendees, over 150 seminar sessions and more than 80 industry partner representations. The ASM offered a range of educational opportunities for members to attain their CPD hours.
The Stripe membership payment gateway was recently introduced for all member and trainee payments. The gateway also allows members to use several payment channels with more user-friendly functionality. Further developments in Stripe will be made in FY25.
Member volunteers maintain a high level of engagement with the College, with over 1,600 members generously contributing their time and efforts in a variety of areas.
Policy and Advocacy
The College actively represented its position to governments and other stakeholders at both federal and state levels across Australia and New Zealand. This program focuses on advocating for access and sustainability of clinical radiology and radiation oncology services, ensuring appropriate
regulation, supporting workforce development, and advancing new technologies.
Financial Outlook FY25
FY25 forecasts sustained resilience in the College’s financial position, with an anticipated surplus of $2 million. This figure is lower than FY24 for several reasons.
Firstly, the College will invest in resources and programs as part of initiating the 2025-2040 Strategy. Secondly, the College will continue to develop ongoing programs relating to hospital accreditation, trainee development, and member support. Thirdly, softening macroeconomic factors are expected to impact external investments and interest income. Additionally, continued price increases for resources and purchases are anticipated. The College is also marginally increasing fees by 2%— below the projected CPI.
As part of the investment framework, the College will be consistently allocating funding to support operational resilience, research, education and aligning to the 2025-2040 Strategy.
The College’s balance sheet, cash position and investment portfolio values are also expected to remain consistently strong through FY25.
FY25 also sees the launch of the 2025 Strategy, as well as new and renewed key government grants. The Federal Government is anticipated to conduct a broader evaluation of the clinical decision support platform ‘iRefer’ with the potential for a scaled roll-out commencing in late 2025.
CEO’S MESSAGE
Writing this column offers a great opportunity to pause and reflect on our journey over the past 12 months and consider the potential pathways that lay ahead.
Corporate governance is one of those things that most members never notice, until it breaks down or goes missing. One of the strengths that originally attracted me to this role was RANZCR’s strong governance structures and the ongoing commitment to good governance at all levels of the College. At the last AGM, RANZCR saw two important governance changes endorsed by membership; the introduction of an independent Chair and the creation of a nominations committee. The nominations committee is now operational and we are well into the search for an interim independent Chair to assist the Board in establishing the role.
RANZCR has been fortunate to have an unbroken line of excellent Presidents who have helped to guide and shape our College. The end of 2023 saw a smooth transition of the President’s role from A/Prof Sanjay Jeganathan to Prof John Slavotinek. In 2024,
Prof Slavotinek has embraced the RANZCR Presidency strongly and with the RANZCR Board, has driven several critical initiatives, including the endorsement of the 2025-2040 Strategic Plan.
At the end of his RANZCR Presidency, A/Prof Jeganathan was elected to the Presidency of the Combined Presidents of Medical Colleges (CPMC), the peak body of the specialist medical colleges, and the first RANZCR Fellow to hold this position. Within 12 months, A/Prof Jeganathan has transformed the CPMC into a vibrant and valuable discussion and advocacy platform for all medical specialists.
The past year has seen an escalation in the volume of work generated for the College by various governments and regulators. I’ve covered this topic in more detail in Inside News, but at a high level, it feels like people forget that the Australian and New Zealand health sectors would be the envy of much of the world, albeit with some significant areas for improvement.
But rather than reinforcing the positives and focusing on real and sustainable change to enable those improvements (which would take time and funding), the focus tends to be on short-term, low-cost, and superficial “solutions”. This might generate a flurry of activity to make stakeholders feel that “something” is being done, but rarely results in the desired improvements.
Even with this extra workload, RANZCR has delivered outstanding results across its Policy and Advocacy platform, excellent training and exam programs for our trainees, and strong ongoing education and collaboration programs for our members and associates. The College continues to provide essential financial
support for innovative sector research and drive transformational projects
RANZCR has also expanded its geographic search for key talent, which has resulted in expanding our Wellington NZ office staff and opening a Melbourne office with a sub-lease inside the College of Surgeons. A highlight of the year was the positive AMC mid-term review of RANZCR’s trainee training program, with RANZCR securing continued approval to deliver the program out to 2026 and an opportunity at that time to have this extended to 2029.
The FY24 saw the development of something new for RANZCR. A true strategic plan covering a 15-year period, out to 2040. This strategic plan consists of three time horizons and sets out a vision of what our College may look like in the future, if it is to remain relevant for its members and remain at the forefront of the sector.
Horizons one and two will position the College to be “matchfit” for this horizon-three future. To achieve the vision within this strategic plan, things we all thought would never be subject to change, will need to change.
Letting go of the past and the present to embrace the future will take courage and leadership.
Fortunately, RANZCR possesses both attributes, in our members and our staff. The College would not be the success it is without the continued support and engagement of the Board, our Faculty Councils, and our wonderful volunteer members.
Moving into the new fiscal year, with your continued support, we will remain at the forefront of medical education and development, research support, and advocacy.
Duane Findley, CEO
THE COLLEGE ONLINE
4,700 X Followers
KEY ACHIEVEMENTS
Advancing Breast Health
RANZCR’s updated position statement advocates for mandatory reporting of mammographic breast density to improve breast cancer screening accuracy. This recommendation underlines the importance of informed decision-making in breast health, acknowledging the significant impact of breast cancer on Australian women.
Advocacy Impact
RANZCR’s decade-long advocacy resulted in a new MBS funding schedule for radiation therapy, effective July 2024. This change reflects a significant milestone in advancing equitable access to essential healthcare services.
AMC Accreditation Achievement
The AMC granted accreditation to RANZCR’s specialist medical programs until 2027, confirming their quality. This maximum permissible period between reviews highlights the excellence of RANZCR’s programs.
Assessment of International Medical Graduates (IMGs)
The College has continued to see a steady increase in the number of applications from International Medical Graduates.
CPD Home
RANZCR is the CPD Home for all members, CPD participants and educational affiliates. The AMC has accredited the College as a CPD Home until 2030.
Guidance on AI Implementation
RANZCR collaborated with international bodies to publish guidance on AI tools in radiology, offering valuable insights into their development, purchase, implementation and monitoring. This initiative supports members and the wider community in navigating the evolving landscape of radiological practice.
Improving Professional Standards in Clinical Radiology
Changes to Recognition of Training in CT Coronary Angiography were introduced in July 2024, following advocacy by members of the Professional Practice Committee. These changes will move to ongoing professional development from logbooks, ensuring the highest quality of care for patients.
Indexation of Nuclear Medicine
Significant achievement with the announcement of $92.8 million allocated in the budget. This funding aims to enhance the viability of nuclear medicine imaging by implementing a targeted schedule fee increase and reinstating annual indexation, thereby aligning with indexation arrangements for other diagnostic imaging modalities.
Increased Training Positions in New Zealand
RANZCR’s ongoing advocacy in conjunction with our New Zealand members has resulted in increased training places for both radiation oncology and clinical radiology.
Introduction of New Clinical Radiology Examination Format
The introduction of a new examination format for Clinical Radiology examinations was completed in 2023. A significant change in the format was the transition from a Viva style examination to an OSCER format. This change was in response to AMC recommendations to provide an examination that is standard-set using best-practice methodology, calibrated to ensure consistency and structured to ensure fairness to all candidates.
Introduction of Selection into Training Policy
Introduction of the Selection into Training Policy and process with the aim to provide all applicants with a fairer, more transparent selection process. The new process provides additional support for Aboriginal, Torres Strait Islander and Māori candidates interested in joining the RANZCR training programs.
Regional and Rural Training Pathway (RRTP) Pilot Program
The RRTP Pilot Program, supported by the Federal Government’s Specialist Training Program, aims to address the unequal distribution of clinical radiologists and radiation oncologists across Australia. Applications from trainees (prospective and existing) and regional and rural training sites to fill the five training positions were sought via an extensive EOI process, commencing in mid 2023. The available five training positions were greatly oversubscribed, with 28 applications from trainees and 13 from training sites seeking to boost their training capacity and grow their medical imaging and radiation oncology workforces. All five training positions have been filled, with successful trainees located in north Queensland, regional New South Wales, northern Victoria, Tasmania, and Top End Northern Territory. In addition, RANZCR has secured funding from the Department of Health and Aged Care for two Indigenous trainee positions under the RRTP program, with funding available for 2025 clinical year. This pilot is the first step in RANZCR’s commitment to developing a long-term, sustainable regional and rural training pathway.
Removal of MRI Licences
RANZCR achieved a significant milestone in its long-standing advocacy efforts for equitable access to MRI services. Following persistent campaigning and collaborative discussions with the Department of Health and Aged Care, the government announced the complete removal of MRI licences by specific dates: from July 2025, practices with existing licences will receive a ‘practice-based’ licence, and by July 2027, all ineligible MRI
machines in comprehensive diagnostic imaging practices will be upgraded for full Medicarefunded MRI services access.
Specialist Training Program
From 2024 clinical year, the College secured funding for two additional Specialist Training Placements and Support (STPS) posts, now 52 STPS posts under the program. As of June 2024, 51 STPS posts were filled, with 36 in clinical radiology and 15 in radiation oncology. More than 70 per cent of these filled posts were regional and rural, located in Modified Monash Model (MMM) 2019 category MMM2 – MMM4. There were 36 STPS regional posts, including six bundled with metropolitan settings. During the period, the number of STPS posts in private settings was 33, which included three posts bundled with public settings.
A total of six funded Integrated Rural Training Pipeline (IRTP) posts were secured and continued to be filled. One new IRTP post commenced in February 2024. It is the first IRTP post for radiation oncology, located in regional NSW (MMM3).
Under Training More Specialist Doctors in Tasmania (TAS Project), two clinical radiology trainee posts and one at 0.5FTE, supervisory post continued to be filled at Royal Hobart Hospital. This marks the full allocation of funding secured under the TAS Project.
Stillbirth Investigation Project Training Package Launch
The RANZCR Perinatal Postmortem Investigation Training Package has been created to provide radiologists with essential skills to conduct perinatal postmortem investigations and set up and manage a perinatal post-mortem imaging service in Australia. The Australian Government provided funding
to RANZCR, via the Department of Health and Aged Care, to develop the Training Package as part of the National Stillbirth Action and Implementation Plan. The Training Package was accepted in its entirety by the Department of Health and was successfully launched in May 2024.
Successful ASM
The 73rd RANZCR Annual Scientific Meeting brought together over 1,500 professionals and industry partners, facilitating learning and collaboration.
Updated Clinical Radiology and Radiation Oncology Training Site Accreditation Standards
After a two-year review period, inclusive of member consultation, the new Clinical Radiology and Radiation Oncology Training Site Accreditation Standards have been approved. The revised accreditation and processes are intended to be:
Encouraging and supportive, to help training sites deliver highquality training.
Simpler and clearer, so it is easier for training sites to know exactly what is expected to meet the requirements.
More comprehensive, to include elements that are frequently identified as key determinants of whether good training is occurring.
Flexible enough to acknowledge that training sites have different ways of achieving the same end point.
More streamlined for all parties, so everyone can be more efficient and timely with decisionmaking and the completion of the necessary documents.
Training sites undergoing accreditation or re-accreditation from 2025 onwards will be assessed against the new standards.
EXAMINATION RESULTS
Phase 1
Phase 2
RADIATION ONCOLOGY
Phase 1 Series 2 2023
25 candidates (66%) met all requirements and passed overall the Phase 1 Examination, and were deemed eligible to progress to Phase 2 of the Radiation Oncology Training Program.
21 candidates (84%) met all requirements and passed overall the Phase 1 Examination, and were deemed eligible to progress to Phase 2 of the Radiation Oncology Training Program.
Phase 2 Series 2 2023
Pass Rate = 43%
Phase 2 Series 1 2024
Pass Rate = 74%
Overall across the 2 series, 23 candidates met all Phase 2 Examination requirements and will be eligible for Fellowship subject to completion all other requirements of the training program or IMG assessment requirements.
AUDITOR’S REPORT
FINANCIALS
The Royal Australian and New Zealand College of Radiologists Statement of profit or loss and other comprehensive income
For the year ended 30 June 2024
The Royal Australian and New Zealand College of Radiologists Statement of financial position As at 30 June 2024
FINANCIALS
The Royal Australian and New Zealand College of Radiologists Statement of changes in equity For the year ended 30 June 2024
The above statement of financial position should be read in conjunction with the accompanying notes, available via www.ranzcr.com
The Royal Australian and New Zealand College of Radiologists Statement of cash flows
For the year ended 30 June 2024
The above statement of financial position should be read in conjunction with the accompanying notes, available via www.ranzcr.com
NEW FELLOWS
ACT
David Newsome
Phillip Hingley
Geetha Guduguntla
NSW
Ta-Chi Zhong Hu
Henry Zhao
Hannah Woodford
Chamitha Weerasinghe
Sean SweeneyKnapp
Shah Rukh Shaikh
Shilpa Sankhe
Danus Ravindran
Liling Patterson
Jyoti Panwar
Ghadah Othman
Sindhura
Nirmalarajan
Teck Leong Eugene Ng
Jacqueline Lubomski
Matthew Leung
Boon Leow
Stewart Leason
Anna Lawless
Krishna Koti
Yasir Khattak
Matthew Holyland
Ge Kai Ho
Caio Hannuch Nascif
Saurabh Gupta
Preetjote Gill
Rueben Ganeshalingam
Alex Feeney
Martin Doss
Vikrant Dhurandhar
Cecil Chen
Joseph Chan
Lucinda Burke
Seamus Brayne
Anzela Anzela
Shiv Aggarwala
NZ
Blanche Wylie
Saidhanya Viswanathan
Feng Yi Soh
John Scotter
Qi Ong
Liam Olsen
Aideen Ni
Mhuineachain
Carla-Louise Morkel
Ingrid Miller
Hugh McHugh
Anna McCool
Anuja Liyanage
Yue Li
Reuben Kirk
Lara Kimble
Willem Ikink
Christopher Fernando
Lance Faber
Joel Dunn
Laura Cosgrave
Matthew Chae
Timothy Allen
Overseas
Georgia Yeo
Hsern Tan
Fawaz Rassam
Mishaal Patel
Peter Nguyen
Declan Neeson
Sravanthi
Mantripragada
Eric Lai
Jeremy Khong
David Hough
Katrina Glazebrook
Vidanelage De Mel
Sian Chin
QLD
Edward Zhong
Michael Williams
Christopher Williams
Felipe Wagner
Azhar Toodayan
Fatima Ragab
Sai Navyan Purchuri
Waseem Nizamani
Patrick Morgan
Matthew Monachen
Ralph Man
Stefanie Lovell
Santosh Kumar
Zubair Ali Khan
Paul Heyworth
James Harvey
Kyle Grabowski
Jayamanee
Govindasamy
Matthew Fielder
Oliver Evison
Zachary Drew
Son Do
Jane Crossin
Timothy Croft
Lee Condon
Manil Chouhan
Amit Chacko
Megan Carroll
Ana Benitez Mendes
SA
Anitha Thalluri
Huey Ming Seah
Amaran Parasuramar
David Ngan
Shirly Lee
Shanesh Kumar
Daniel Koh
Barrett Jarrell
Karim Hussein
Andrew Goldfinch
Elisa Chia
Adam Byrne
Alice Andrawos
TAS
Cara Lucas
Conrad Jackson
Maxwell Howcroft
Lasanka De Silva
VIC
Bob Zhang
Mary Xu
Janki Trivedi
Victor Tang
Julia Sun
Emily Stevens
Thenugaa Sritharan
Lilly Shen
Roland Shannon
Jarrel Seah
Sharanya Sankaran
Mahwash Rehan
Ramin Pourghorban
Hardik Patel
Archan Patel
Margaret Nguyen
Brian Ngo
Alexandra Murphy
Rowan Miller
Peter Mark
Ha Lu
Andrew Long
James Lisik
Lee Lim
Bianca Lenffer
Renuka Kunju Krisnan
Maria Kirkinis
Sohyun Kim
Therese Kang
Zoe Hutchinson
Adam Hussain
Michael Hsieh
Kenji Hinde
Nilesh Gupta
Jarrod Greenhalgh
Jacob Gipson
Sijing Feng
Malachy Feeney
Orla Dunlea
Sam Digby
Matthew Denton
Ariel Dahan
Lucy Corlette
Benjamin Chosich
Vikash Chennur
Anni Chen
Yan Shan Chee
Kateryna Burlak
Daniel Brennan
James Bender
Farrukh Arfeen
Kutayba Adam
WA
Miltiadis Vouros
Jonathan Toby
Derek Teh
Samantha Tan
Sajith Senadeera
Anthony Robinson
Chandrika
Ranasinghe
Arachchige
Colin-John Perrins
Nik Mohd Harris bin
Nik Hussin
Edward Nganga
David Malem
Yasmin Lunney
Ying Cheong Lee
Ju-Won Lee
Sagarika Kulawansa
Timothy Jeffery
Duminda Hitapu
Ralalage
Rakesh Gadvi
Scott Fleming
Portia D'anverrs
Teck Jian Choo
Peng Loon Cheah
COLLEGE GRANTS, AWARDS AND PRIZES
College
Honours
Gold Medal
Dr Gregory Slater
Roentgen Medal
Dr Sean Brennan
Prof Alan Coulthard
Honorary Fellowship
Dr Howard B Fleishon
Prof Adrian Brady
Clinical Radiology Educational Service Award
Dr Graeme Anderson
Life Membership
A/Prof Anthony Doyle
Dr Arlene Mou
RANZCR Community Services Award
Dr David Schlect Research Awards and Grants
Faculty of Radiation
Oncology Bourne and Langlands Prize
Dr Therese Kang
Clinical Radiology Early Career Researchers Prize
Dr Pey Ling Shum
Radiation Oncology Research Grants
Dr Yuvnik Trada,
A/Prof Peter Gorayski
Dr Kylie Jung
Dr Beini Chen
Dr Su Chen Fong
A/Prof Wee Loon Ong
A/Prof Mei Ling Yap
Clinical Radiology Research Grants
Dr Jeanette McGill
Dr Sally Ayesa
Dr Min-Son To
Indigenous Health Prize
Dr Ieta D’Costa
Quality Improvement
Project Prize
A/Prof Sandra Turner
Bourne and Langlands Prize
Dr Therese Kang
ASM Prize
Recipients
Medical Wealth Advisory – Clinical Radiology Rural and Regional Award
Dr Benjamin Ong
Medical Wealth Advisory – Radiation Oncology Rural and Regional Award
Dr Pavthrun Pathmanathan
Wiley Best Exhibit Award - Radiation Oncology
Dr Chia Low
Branch of Origin Prize
Dr Hugh McHugh
Chris Atkinson Award
A/Prof Shankar Siva
Elekta Award
A/Prof Shankar Siva
FROGG Prize
A/Prof Wee Loon Ong
Varian Prize
Dr Benjamin Challis
Varian Prize
Dr Alexandra Powell
Wiley Best Exhibit Award - Clinical Radiology
Dr Arjuna Somasundaram
Best IR Presentation
Dr Emily Stevens & Dr Liam McAuliffe
Educational Fellowships
Thomas Baker Fellowship
Dr Aaron Kent
Bill Hare Fellowship
Dr Emmeline Lee
Exam Prizes
CE Eddy Prize Radiation Oncology
Dr Joshua Liu
CE Eddy Prize Clinical Radiology
Dr Ann-Marie Nguyen
Dr Wei Shyan Soon
Branch Awards
Obex Medical Registrar Research Award (NZ)
Dr High McHugh
FRONNZ Prize (NZ)
Dr Katherine Tse
NZRET Poster Prize
Dr Kyle Grabowski
SPONSORS
We acknowledge the valuable support provided by the following sponsors throughout the year:
3M Australia Pty Ltd
4DMedical
Abbott Medical Pty Ltd
AdvaHealth Solutions Pty Ltd
AGFA HealthCare
AIRS Medical Inc.
Alocuro
alphaXRT
Annalise.Ai
Arthrex Australia Pty Ltd
AstraZeneca
ATEC Spine
Australian Digital Health Agency
Avant Practice Solutions
Bayer
BD
Bio Excel Australia Pty Ltd
Blackford Analysis
Boehringer Ingelheim Pty Ltd
Boston Scientific Pty Ltd
Brainlab Australia Pty Ltd
Cancer Care Associates
Canon Medical Systems ANZ
Capitol Health
Carlisle Health Pty Ltd
CARPL.ai, Inc.
COPE Sensitive Freight
Eagleheart Health Spaces
Eizo APAC
Elekta Pty Ltd
Encanta Event Management
Epic-X
Everlight Radiology
Ever-X Pty Ltd
eviQ - Cancer Institute NSW
Fujifilm Australia
GE HealthCare Australia Pty Ltd
Getz Healthcare Pty Ltd
Guerbet
Healthinc Pty Ltd
HosPortal Pty Ltd
I-MED Pty Ltd
iMedX Australia & New Zealand
Inline Systems
Integral Diagnostics (IDX)
Integrated Clinical Oncology
Network PTY LTD
Intelerad Medical Systems Inc
Interfuse Technologies Pty Ltd
Interite Healthcare (ICI Nominees)
Kestral
LG Electronics
Life Healthcare
Lumus Imaging
Lungscreen
MDA National
Medality, formerly MRI Online
Medfin Finance
Medical Physics Specialists
Medtronic Australasia Pty Ltd
Merit Medical
Mundipharma
Noble Oak Nuance
Oncobeta
Oxlade Financial Solutions
OzDoc Solutions Partnership P/L
Penumbra, Inc.
Performance Property
Philips
Professional Radiology Outcomes
PRP Diagnostic Imaging
Q-Scan Services Pty Ltd
RaySearch Laboratories
Reynolds Medical Solutions
Sectra
See-Mode Technologies
Siemens Healthineers
Sirtex Medical
Soliton IT
Stratpharma
Stryker
Terumo Australia Pty Ltd
The Ohio State University
United Imaging
Varian
Vengage Pty Ltd
Vestone Capital
Voyager Imaging
Xwave Technologies
DECEASED MEMBERS
It is with regret that we record the deaths of the following members during the year under review:
David Tay Sang Fong, Fellow, NSW
Bernard Francis Vaughan, Life Member, SA
Judith Anne Cox, Fellow, QLD
Susan Jane Mincham, Fellow, WA
William Duncan, Honorary, Overseas
